Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:30 pm Sale | 2024-09-30 | 13G | GLYCOMIMETICS INC GLYC | Invus Public Equities, L.P. | 19,651 3.000% | -33,234 (-62.84%) | Filing History |
| 2024-11-06 5:41 pm Purchase | 2024-10-30 | 13G | GLYCOMIMETICS INC GLYC | RA Capital Management, L.P. | 63,830 9.900% | 63,830 (New Position) | Filing History |
| 2024-11-04 4:26 pm Purchase | 2024-10-29 | 13D | GLYCOMIMETICS INC GLYC | Adage Capital Management, L.P. | 50,912 7.900% | 50,912 (New Position) | Filing History |
| 2024-11-04 2:01 pm Sale | 2024-10-30 | 13G | GLYCOMIMETICS INC GLYC | Weinstein Benjamin | 500 0.100% | -33,539 (-98.53%) | Filing History |
| 2024-08-15 5:01 pm Sale | 2024-08-13 | 13G | GLYCOMIMETICS INC GLYC | Invus Public Equities, L.P. | 52,885 8.200% | -33,006 (-38.43%) | Filing History |
| 2024-08-14 4:13 pm Purchase | 2024-08-09 | 13G | GLYCOMIMETICS INC GLYC | Weinstein Benjamin | 34,039 5.300% | 34,039 (New Position) | Filing History |
| 2024-07-29 7:24 pm Purchase | 2024-07-25 | 13G | GLYCOMIMETICS INC GLYC | Invus Public Equities, L.P. | 85,891 13.300% | 85,891 (New Position) | Filing History |
| 2024-05-08 5:06 pm Sale | 2024-05-06 | 13D | GLYCOMIMETICS INC GLYC | New Enterprise Associates 10, Limited Partnership | 21,819 5.000% | -18,261 (-45.56%) | Filing History |
| 2024-02-29 7:28 pm Sale | 2024-02-06 | 13D | GLYCOMIMETICS INC GLYC | New Enterprise Associates 10, Limited Partnership | 40,080 6.200% | -7,139 (-15.12%) | Filing History |
| 2024-02-12 4:48 pm Sale | 2024-02-06 | 13D | GLYCOMIMETICS INC GLYC | New Enterprise Associates 10, Limited Partnership | 47,219 7.300% | -2,456 (-4.94%) | Filing History |
| 2024-02-09 5:03 pm Purchase | 2023-12-31 | 13G | GLYCOMIMETICS INC GLYC | Artal Participations S.a r.l. | 85,891 13.300% | 20,153 (+30.66%) | Filing History |
| 2024-01-29 4:31 pm Unchanged | 2023-03-29 | 13G | GLYCOMIMETICS INC GLYC | BIOTECHNOLOGY VALUE FUND L P | 95,443 14.800% | 0 (Unchanged) | Filing History |
| 2023-02-13 5:18 pm Purchase | 2023-02-09 | 13G | GLYCOMIMETICS INC GLYC | Artal Participations S.a r.l. | 65,738 12.500% | 65,738 (New Position) | Filing History |
| 2023-02-10 5:23 pm Sale | 2023-01-26 | 13D | GLYCOMIMETICS INC GLYC | New Enterprise Associates 10, Limited Partnership | 49,675 9.500% | -41,438 (-45.48%) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | GLYCOMIMETICS INC GLYC | VANGUARD GROUP INC | 22,386 4.330% | -3,306 (-12.87%) | Filing History |